newsfilter
← Latest News
Business Wire·

Magenta Therapeutics Appoints Steve Mahoney as Chief Financial and Operating Officer

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Magenta Therapeutics (NASDAQ: MGTA), a clinical-stage biotechnology company developing novel medicines to bring the curative power of immune reset to more patients, today announced the appointment of Steve Mahoney as Chief Financial and Operating Officer.